Pharma & Biotech

Investors in Bristol-Myers Squibb encountered a significant market downturn as the pharmaceutical giant and its collaborator, Johnson & Johnson, terminated...

Investor attention is firmly fixed on Arrowhead Pharmaceuticals this week as the biotechnology firm approaches two significant milestones that could...

Eli Lilly shares are positioned for a strong week following two significant developments from opposite sides of the Atlantic. The...

Redcare Pharmacy is making a decisive move to restore investor confidence by appointing a seasoned e-commerce executive as its new...

IO Biotech faces a pivotal moment in its corporate history as financial pressures mount and regulatory challenges intensify. The biotechnology...

MannKind Corporation finds itself at a critical juncture as conflicting signals emerge from its recent corporate developments. While the biopharmaceutical...

Vapotherm has achieved a significant regulatory milestone with the U.S. Department of Defense granting operational approval for its HVT® 2.0...

The curtain is closing on ViewRay as the company enters the final stage of its corporate existence. With the bankruptcy...

The biotechnology sector has a new standout performer, and its name is Liquidia. The company is currently authoring one of...

The Danish pharmaceutical giant Novo Nordisk finds itself navigating its most significant corporate crisis in recent memory. A dramatic sequence...